2020-2025 Global Biologics and Biosimilars Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Biosimilars are biomedical products that are almost identical to the original products made by different companies. Biosimilars are officially recognized versions of the original "innovator" products that can be produced when the original product patent expires. Reference to innovative products is an integral part of the approval.
This report elaborates the market size, market characteristics, and market growth of the Biologics and Biosimilars industry, and breaks down according to the type, application, and consumption area of Biologics and Biosimilars. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biologics and Biosimilars in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Biologics and Biosimilars market covered in Chapter 13:
Pfizer
Dong Bao
Changchun High Tech
Innovent
Ganlee
Biotech
Eli Lilly
AbbVie
Novo Nordisk
3sbio
Roche
Novartis
CP Guojian
Johnson & Johnson
Merck
Gelgen
Sanofi-Aventis
Amgen

In Chapter 6, on the basis of types, the Biologics and Biosimilars market from 2015 to 2025 is primarily split into:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other

In Chapter 7, on the basis of applications, the Biologics and Biosimilars market from 2015 to 2025 covers:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025